Skelaxin Generics May Launch Before July 2005: FDA To Allow Labeling "Carve Out"
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency says ANDA filers Eon and Corepharma may delete protected labeling on food effects covered by King’s method-of-use patent.